Global Journal of Medical Research, F: Diseases, Volume 22 Issue 6

Comorbidity ≥is determined by a 45.7 percent prevalence in the general population of 18–70-year-old farmers (Table 4) and exhibits age-dependent formation characteristics. It is noted in different ages with a specific distribution: • 18-30 years old - 20.0%; • 31-49 years - 49.9% (with a 2.5-fold increase; R <0.01); • 50-69 years - 27.9% (with a 1.3-fold increase; R <0.05); • ≥At the age of 70 - 2.2% (with a decrease of 10 times; R <0.001). Table-4: Epidemiological characterization of comorbidity in the farming population Note:• Xi 2 = 0.05; • RR = 1.01; • R > 0.05. 17 Year 2022 Global Journal of Medical Research Volume XXII Issue VI Version I ( D ) F © 2022 Global Journals Features of the Clinical Course of Urinary Stone Disease in the Farming Population Inspection groups Age groups 18-30 years old 31-49 years old 50- 69 years old ≥70 years old ≥18-70 years old In the absolute number Percentage In the absolute number Percentage In the absolute number Percentage In the absolute number Percentage In the absolute number Percentage Farmers are men 38 52.1 98 53.9 IT 74 72.6 x 5 62.5 x 215 58.9 R <0.005 <0.005 <0.005 <0.005 <0.005 Farmers are women 35 47.9 84 46.2 IT 28 27.5 x 3 37.5 x 150 41.1 The general population of farmers 73 20.0 182 49.9 xx 102 27.9 x 8 2.2 xxx 365 45.7 With age, comorbidity is detected at different frequencies or observed with a difference. This epidemiologically specific gender view is evident in the following percentage frequencies in male farmers and women: • 18-30 years - from 52.1% and 47.9% (R <0.005); • 31-49 years - 53.9 percent (increased by 1.8 percent, R> 0.05) and 46.2 percent (decreased by 1.7 percent, R> 0.05), R <0.005; • 50-69 years - 72.6 percent (increased by 20.5 percent, R <0.05) and 27.5 percent (decreased by 20.4 percent, R <0.05), R <0.005; • ≥At the age of 70 - 62.5% (increased to 10.4%, R <0.05); R> 0.005; • 37.5 percent (with a decrease of 10.4 percent, R <0.05); R> 0.005. 1. Arutyunov G. P., Tarlovskaya E. I., Arutyunov A. G., Belenkov Yu.N. and dr. International Register "Analysis of the dynamics of comorbidities in patients with advanced SARS - COV -2 (ACTIVE SARS ) COV –2)”: Analysis of 1000 patients // Rossiyskiy kardiologicheskiy journal. - 2020. - 25 (11): 98-107. 2. Kayumova M. M., Akimov M. Yu., Gafarov V. V. Populyatsionnye vrajdebnosti sredi naseleniya sredneurbanizirovannogo naseleniya Sibirskogo goroda: vozrastn ы e i gendernye aspekty // Rossiyskiy kardiologicheskiy zhurnal. 25 (6): 68-72. 3. Chasovskix G. A. Issledovaniya evolyutsii morali kak kommunikativnyy instrument v otnoshenii vrach- patsient // Rossiyskiy kardiologicheskiyurnal. - 2020, - 25 (9): 60-65. 4. Shestaev A. Yu., Protoshchak V.V., Paronnikov M. V., Kiselov A. O. Kombinirovannyy (citratnyy i rastitelnyy) preparations of uric acid in distant lithotripsy and metaphylactic urinary tract disease// Urologicheskie vedomosti. - 2018. - Tom8. - № 1. - S. 19-25. 5. Avdoshin VP, Andrukhin MI, Israfilov MN Kompleksnoe Iechenie I metaphylaxis uratnogo I smeshannogo urolithiasis// Moscow: Special issue ;2013. 6. Kaprin AD. Apolikhin OI, SivKov Av et al. Analysis of uronephrological morbidity and mortality in the Russian Federation for the period 2002-2014 according to official statisies// Experimental and clinical erology.- 2016; (3): 4-13. 7. Voshhula VI Mocherfmennya bolezn: etiotropnol I pathogenetiches - Koe Iechenie , prophylaxis - Minsk :VEVEKE ;2006. 8. Kasote DM, Jadtap SD, Thapa D. et al. Herbal remedies for urinary stones used in India and China: A review// J Ethnopharmacol.- 2017 :203 :55-68.doi: 10.1016 / j.jep.2017.03.038. 9. Turk G, Petrik A, Sarica K. et al EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis// EUR UROL.- 2016; 69 (3): 468-474. doi :10.1016 / j.eururo.2015.07.040. R eferences R éférences R eferencias